Literature DB >> 6089810

Glyoxalase I in regenerating mouse liver exposed to carcinogens.

A Dixit, L C Garg, P Sutrave, A R Rao.   

Abstract

Glyoxalase I is the first component of glyoxalase system which is involved in detoxification of alpha-ketoaldehydes and converts them to nontoxic substances. This study reports changes in Glyoxalase I activity in relation to DNA synthesis in regenerating liver treated with two polycyclic aromatic hydrocarbons - 7,12-dimethylbenz (a) anthracene and benzo(a)pyrene. Livers after partial hepatectomy show consistent increase in Gly. I which reaches to its peak at 24 hr after surgery. [3H]Thymidine incorporation into DNA also follows the same trend as does Gly. I in regenerating liver. Both the carcinogens have significantly reduced the activity of Gly. I and DNA biosynthesis when compared with untreated partially hepatectomized control livers. The study reveals that though regenerating liver has been considered as an experimental model for neoplasia, unlike tumors (where Gly. I is either absent or in undetectable quantities) it possesses more Gly. I than in normal liver. On the other hand, preneoplastic liver during initiation (in regenerating liver treated with carcinogens, initiation is expected to occur) has very low activity. This suggests that Gly. I is not only involved in controlling growth but possibly is involved in some other phenomenon which is somehow depressed in preneoplastic and cancerous tissues.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6089810

Source DB:  PubMed          Journal:  Biochem Int        ISSN: 0158-5231


  2 in total

Review 1.  The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life.

Authors:  P J Thornalley
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

Review 2.  Metabolic Shades of S-D-Lactoylglutathione.

Authors:  Miklós Péter Kalapos; Cinzia Antognelli; Lidia de Bari
Journal:  Antioxidants (Basel)       Date:  2022-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.